Clinical Trial Update: Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating memory-enriched T cells for recurrent or refractory Grade III-IV glioma, including glioblastoma and malignant glioma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Glioma

Drugs mentioned

• Memory Enriched T Cells

Snippet

Sponsor: City of Hope Medical Center | Conditions: Glioblastoma, Malignant Glioma | Phase 1 | Status: ACTIVE_NOT_RECRUITING